Abstract
Interferon regulatory factor 8 (IRF8) is a transcription factor necessary for the maturation of microglia, as well as other peripheral immune cells. It also regulates the transition of microglia and other immune cells to a pro-inflammatory phenotype. Irf8 is also a known risk gene for multiple sclerosis and lupus and it has recently been shown to be downregulated in schizophrenia. While most studies have focused on IRF8-dependent regulation of immune cell function, little is known about how it impacts neural circuits. Here, we show by RNAseq from Irf8-/- male and female mouse brains that several genes involved in regulation of neural activity are dysregulated. We then show these molecular changes are reflected in heightened neural excitability and a profound increase in susceptibility to lethal seizures in male and female Irf8-/- mice. Finally, we identify that TNF-α is elevated specifically in microglia in the CNS and genetic or acute pharmacological blockade of TNF-α in the Irf8-/- central nervous system (CNS) rescued the seizure phenotype. These results provide important insights into the consequences of IRF8 signaling and TNF-α on neural circuits. Our data further suggest that neuronal function is impacted by loss of IRF8, a factor involved in neuropsychiatric and neurodegenerative diseases.
SIGNIFICANCE STATEMENT
Here, we identify a previously unknown and key role for Interferon regulator factor 8 (IRF8) in regulating neural excitability and seizures. We further determine these effects on neural circuits are through elevated TNF-α in the CNS. As IRF8 has most widely been studied in the context of regulating the development and inflammatory signaling in microglia and other immune cells, we have uncovered a novel function. Further, IRF8 is a risk gene for multiple sclerosis (MS) and lupus, IRF8 is dysregulated in schizophrenia, and elevated TNF-α has been identified in a multitude of neurological conditions. Thus, elucidating these IRF8 and TNF-α-dependent effects on brain circuit function have profound implications for understanding underlying, therapeutically-relevant mechanisms of disease.
Footnotes
The authors declare no conflict of interest.
We thank Dr. Marco Prinz for sending us the Irf8-/- mice, which were originally made by Holtschke et al. (Holtschke et al., 1996). This work was funded by NIMH-R01MH113743 (DPS), NIA-RF1AG068281 (DPS), Massachusetts Life Sciences Center (DPS), the Brain and Behavior Research Foundation NARSAD (DPS), Autism Speaks Weatherstone Predoctoral Fellowship 11779 (PAF), NIA-R01AG062840 (RKS) and NIA-R01AG072896 (RKS), R01NS119597 (CA), NIMH-MH103399 (CA), Coins for Alzheimer’s Disease Research (CART, CA), Citizens United for Research in Epilepsy (CURE, CA), BrightFocus Foundation #A2020321S (CA), Natural Sciences and Engineering Research Council (NSERC) of Canada (DS)
Jump to comment: